By expenditures
| Name | Title | Type |
|---|---|---|
| Stacey Duszlak | Cfo | Auditee |
| Jennifer Curtis | EXECUTIVE DIRECTOR | Auditee |
| Jeffrey Alvanas | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 376433 | 2025 | 2025-12-19 | CITRIN COOPERMAN | $6.60M |
| 346186 | 2024 | 2025-03-14 | Citrin Cooperman & Company LLP | $5.63M |
| 3655 | 2023 | 2023-11-17 | Citrin Cooperman & Company LLP | $6.54M |
| 24058 | 2022 | 2023-04-30 | Citrin Cooperman & Company | $6.62M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 3655 | 2023 | 2023-11-17 | 578549 | 2023-001 | Significant Deficiency | - | L |
| 3655 | 2023 | 2023-11-17 | 578548 | 2023-001 | Significant Deficiency | - | L |
| 3655 | 2023 | 2023-11-17 | 578547 | 2023-001 | Significant Deficiency | - | L |
| 3655 | 2023 | 2023-11-17 | 2107 | 2023-001 | Significant Deficiency | - | L |
| 3655 | 2023 | 2023-11-17 | 2106 | 2023-001 | Significant Deficiency | - | L |
| 3655 | 2023 | 2023-11-17 | 2105 | 2023-001 | Significant Deficiency | - | L |
| 24058 | 2022 | 2023-04-30 | 610731 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 610730 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 610729 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 610728 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 34289 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 34288 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 34287 | 2022-003 | Material Weakness | - | L |
| 24058 | 2022 | 2023-04-30 | 34286 | 2022-003 | Material Weakness | - | L |